Lunit Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
312
- Stock Symbol
-
328130
- Investments
-
2
- Share Price
-
$12.15
- (As of Friday Closing)
Lunit General Information
Description
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.
Contact Information
Website
www.lunit.ioCorporate Office
- 4th Floor to 9th Floor, 374 Gangnam-daero
- Gangnam
- Seoul, 06241
- South Korea
Corporate Office
- 4th Floor to 9th Floor, 374 Gangnam-daero
- Gangnam
- Seoul, 06241
- South Korea
Lunit Stock Performance
As of 20-Nov-2026, Lunit’s stock price is $12.15. Its current market cap is $905M with 74.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.15 | $12.53 | $5.74 - $16.63 | $905M | 74.5M | 1.49M | -$1.14 |
Lunit Financials Summary
As of 30-Sep-2026, Lunit has a trailing 12-month revenue of $64.7M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 545,410 | 884,419 | 1,240,631 | 1,783,856 |
| Revenue | 64,716 | 58,413 | 39,708 | 19,183 |
| EBITDA | (43,308) | (8,307) | (47,937) | (25,790) |
| Net Income | (70,532) | (33,299) | (60,608) | (28,145) |
| Total Assets | 319,761 | 256,881 | 293,906 | 207,903 |
| Total Debt | 62,876 | 77,488 | 49,186 | 15,413 |
Lunit Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lunit Comparisons
Industry
Financing
Details
Lunit Competitors (15)
One of Lunit’s 15 competitors is HeartFlow, a Formerly VC-backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HeartFlow | Formerly VC-backed | Mountain View, CA | ||||
| Vista (Decision/Risk Analysis) | Venture Capital-Backed | Redwood City, CA | ||||
| Paige | Formerly VC-backed | New York, NY | ||||
| DeepWise (Enterprise Systems) | Venture Capital-Backed | Beijing, China | ||||
| HealthMyne | Formerly VC-backed | Madison, WI |
Lunit Patents
Lunit Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026177336-A1 | Method and device for outputting medical information about subject by using machine-learning model | Pending | 21-Feb-2025 | ||
| EP-4797222-A1 | Method and apparatus for analyzing pathological slide image | Pending | 19-Feb-2025 | ||
| US-20260245385-A1 | Method and apparatus for analyzing pathological slide image | Pending | 19-Feb-2025 | ||
| JP-2026139036-A | Method and apparatus for analyzing pathology slide images | Pending | 19-Feb-2025 | ||
| WO-2026151096-A1 | Method and apparatus for outputting medical information | Pending | 09-Jan-2025 |
Lunit Signals
Lunit Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lunit Investments & Acquisitions (2)
Lunit’s most recent deal was a Corporate Asset Purchase with Prognosia (Core Technology Asset in Seoul, South Korea). The deal was made on 01-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prognosia (Core Technology Asset in Seoul, South Korea) | 01-Jun-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Volpara Health Technologies | 21-May-2024 | Merger/Acquisition | Monitoring Equipment |
Lunit ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
14.45 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Health Care IT Services
Subindustry
of 50
Rank
Percentile
Lunit Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Volpara Health Technologies | Wellington, New Zealand | 2009 |
Lunit FAQs
-
When was Lunit founded?
Lunit was founded in 2013.
-
Where is Lunit headquartered?
Lunit is headquartered in Seoul, South Korea.
-
What is the size of Lunit?
Lunit has 312 total employees.
-
What industry is Lunit in?
Lunit’s primary industry is Decision/Risk Analysis.
-
Is Lunit a private or public company?
Lunit is a Public company.
-
What is Lunit’s stock symbol?
The ticker symbol for Lunit is 328130.
-
What is the current stock price of Lunit?
As of 20-Nov-2026 the stock price of Lunit is $12.15.
-
What is the current market cap of Lunit?
The current market capitalization of Lunit is $905M.
-
What is Lunit’s current revenue?
The trailing twelve month revenue for Lunit is $64.7M.
-
Who are Lunit’s competitors?
HeartFlow, Vista (Decision/Risk Analysis), Paige, DeepWise (Enterprise Systems), and HealthMyne are some of the 15 competitors of Lunit.
-
What is Lunit’s annual earnings per share (EPS)?
Lunit’s EPS for 12 months was -$1.14.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process